India’s Ranbaxy Laboratories in U.S. Legal Probe

July 14, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

NEW DELHI, July 14 (Reuters) - Shares in India's Ranbaxy Laboratories Ltd fell 10 percent on Monday, their biggest drop in 7 years, on concerns a U.S. probe against the drug maker may hit sales in a market responsible for a quarter of its sales.

Twitter
LinkedIn
Facebook
Email
Print

Legal Regulatory Asia